Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion

Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion

April 5, 2024

Healthcare Services

Johnson & Johnson (JNJ) entered into a definitive agreement to acquire all outstanding shares of Shockwave Medical for $335.00 per share in cash, implying an enterprise value of about $13.1 billion. The deal expands J&J MedTech’s cardiovascular intervention portfolio—adding Shockwave’s intravascular lithotripsy (IVL) technology for calcified coronary and peripheral artery disease.

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed through a tender offer and subsequent merger, for an upfront payment of $380.00 per share in cash (enterprise value ~ $16.6 billion), plus a non-tradeable contingent value right (CVR) up to $35.00 per share based on milestones. Abiomed will operate as a standalone business within Johnson & Johnson’s MedTech segment.

Shockwave Medical Acquires Neovasc

January 17, 2023

Medical Devices

Shockwave Medical entered into a definitive agreement to acquire Neovasc, a minimally invasive treatment company focused on refractory angina. Under the plan of arrangement, Neovasc shareholders will receive $27.25 per share in upfront cash plus contingent value right (CVR) payments tied to regulatory milestones.

Boston Scientific to Acquire SoniVie Ltd

March 3, 2025

Medical Devices

Boston Scientific Corporation has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company developing the TIVUS intravascular ultrasound system for renal denervation therapy for hypertension. The deal includes an upfront payment of approximately $360 million for the 90% stake Boston Scientific does not already own, plus up to $180 million contingent on achievement of a regulatory milestone.

JLL Partners Invests in Vascular Technology, Incorporated

June 30, 2025

Medical Devices

JLL Partners, a New York-based middle market private equity firm, has announced an investment in Vascular Technology, Incorporated (VTI), a Nashua, New Hampshire-based medical device company that develops intraoperative Doppler systems and remote suction/irrigation solutions. As part of the transaction JLL partnered with entrepreneur Nilendu Srivastava and the VTI management team and appointed Greg Groenke as CEO and Lars Marcher as Executive Chairman to accelerate product development and market expansion.

Siemens Healthineers to Acquire Varian Medical Systems

August 2, 2020

Medical Devices

Siemens Healthineers AG has agreed to acquire all shares of Varian Medical Systems, Inc. for USD 177.50 per share, valuing the deal at approximately USD 16.4 billion. The transaction, which aims to create an integrated cancer-care portfolio, is expected to close in H1 2021 subject to Varian shareholder and regulatory approvals.